Concepedia

Christopher Sondey

CS

Statistics

Publications

13

Citations

295

H-Index

12

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Quantitative BioSciences

United States Military Academy

Albany Molecular Research (United States)

Albany Molecular Research (Singapore)

Christopher Sondey is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2009–2022

13

Publications

13

Synthesis and structure–activity relationships of 2-(1,4′-bipiperidin-1′-yl)thiazolopyridine as H3 receptor antagonists

Ashwin U. Rao, Anandan Palani, Ying Huang et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 40 citations · Full text

, , +8

Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation

William T. McElroy, Zheng Tan, Ginny D. Ho et al. · ACS Medicinal Chemistry Letters · 2015 · 40 citations · Full text

, , +13

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

R.L. Palte, Sebastian E. Schneider, Michael D. Altman et al. · ACS Medicinal Chemistry Letters · 2020 · 38 citations · Full text

Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 Inhibitors

W. Michael Seganish, Thierry Fischmann, Brad Sherborne et al. · ACS Medicinal Chemistry Letters · 2015 · 27 citations · Full text

, , +15

Discovery of a Potent Thiadiazole Class of Histamine H<sub>3</sub> Receptor Antagonist for the Treatment of Diabetes

Ashwin U. Rao, Ning Shao, Robert Aslanian et al. · ACS Medicinal Chemistry Letters · 2011 · 23 citations · Full text

, , +15

1–5 of 13